Ministry of Public Health, Maysan Health Department, Maysan governorate, Iraq
*Corresponding author: Rafid Hadi Hameed. Ministry of Public Health, Maysan Health Department, Maysan governorate, Iraq; E-mail: rafidhadii@gmail.com
Online published on 27 November, 2019.
The incidence of myocardial infarction (MI) continues to increase. The increase is further encouraged through using non-steroidal anti-inflammatory drugs (NSAIDs) to treat various conditions. Some of the conditions include spondyloarthritis (SpA) and osteoarthritis (OA). This study analyses the risk of MI in SpA and OA patients who use NSAIDs. The study did a systematic review and meta-analysis of cohort studies in an adult population with the minimum age for participants being 18 years. There was evidence that the risk for MI in SpA and OA patients increases due to the use of NSAIDs. This was in comparison to persons and patients who do not use NSAIDs. Other factors like age, gender, finance, and diet were also considered in the study. The use of NSAIDs increases the risk of MI among SpA and OA patients. There is, therefore, a need for alternative medication for the two conditions.
Spondyloarthritis (SpA), osteoarthritis (OA), myocardial infarction, and non-steroidal anti-inflammatory drugs (NSAIDs)
You're Invited! ONOS User Webinar
21 July 2026 | 4:00 PM IST